Actively Recruiting
Genetic and MRI Biomarkers of Neuroplasticity Predict Aphasia Recovery and Phenotypes
Led by University of Wisconsin, Madison · Updated on 2025-10-23
90
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
University of Wisconsin, Madison
Lead Sponsor
N
National Institutes of Health (NIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Aphasia, a language disorder often resulting from stroke, can cause serious challenges including social isolation and reduced quality of life. Recovery from aphasia varies widely among individuals and depends on the brain's ability to reorganize and repair itself through neuroplasticity at both network and molecular levels. This research aims to study genetic and brain network markers linked to neuroplasticity to better understand variations in aphasia recovery and to support future development of personalized treatments. Participants will engage in a behavioral pseudoword learning task where they view pairs of novel objects and hear names of one object, responding by identifying the correct item. This task includes multiple learning blocks with feedback and test blocks assessing immediate and retained learning. The study will measure genetic markers and brain connectivity through MRI to explore their connections with language recovery over time. During the study, participants will be assessed at several time points up to at least one year post-stroke. Evaluations include aphasia severity, semantic, phonological, noun and verb processing, pseudoword learning, and verbal learning. Researchers will use these measures alongside genetic and MRI data to understand recovery patterns. The study spans multiple months involving follow-up assessments to monitor progress and outcomes, with the goal of improving aphasia prognosis and treatment strategies.
CONDITIONS
Brief Title
Neuroplasticity Biomarkers in Aphasia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 40 to 90 years
- Right-handed before stroke
- Proficient in English
- History of a single ischemic stroke in the middle cerebral artery territory lateralized to the left or right cerebral hemisphere
- Presence of aphasia (language impairment)
- Ability to understand the study and provide informed consent
- For Aim 1: acute or subacute stroke at enrollment
- For Aims 2-3: stroke at least 12 months old (chronic)
- Medically stable
You will not qualify if you...
- History of significant medical or neurological disorders other than stroke
- History of significant or poorly controlled psychiatric disorders
- Current abuse of alcohol or drugs
- Clinically significant and uncorrected vision or hearing loss
- Receipt of treatments beyond standard stroke care such as Plavix, aspirin (81-300 mg daily), beta-blockers, diabetes or cholesterol medications, thrombolytics (e.g., tPA), or anticoagulants like Heparin, Warfarin/Coumadin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 1 week
Participants complete a behavioral pseudoword learning task involving multiple trials and learning blocks designed to assess language processing and verbal learning.
1 baseline visit and 1 follow-up visit
Duration - Up to 1 year post-stroke
Participants are observed over time to assess aphasia recovery and language function through follow-up assessments at multiple timepoints post-stroke.
Visits at 3 months, 6 months, and 1 year post-stroke
Trial Site Locations
Total: 1 location
1
UW School of Medicine and Public Health
Madison, Wisconsin, United States, 53792
Actively Recruiting
Research Team
H
Haley Dresang, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here